Disparity between levels of anti-RBD IgG and anti-nucleocapsid protein IgG antibodies in COVID-19-recovered patients who received a kidney transplant.

Autor: Chang CC; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA. Electronic address: cc55@cumc.columbia.edu., Vlad G; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA., Vasilescu ER; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA., Husain SA; Department of Medicine, Division of Nephrology, Columbia University Irving Medical Center, New York, New York, USA; Department of Epidemiology, The Columbia University Renal Epidemiology (CURE) Group, Columbia University, New York, New York, USA., Liu YN; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA., Sun WZ; Department of Anesthesiology, National Taiwan University Hospital, Taipei, Taiwan., Chang MF; Institute of Biochemistry and Molecular Biology, National Taiwan University, Taipei, Taiwan., Suciu-Foca N; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA., Mohan S; Department of Medicine, Division of Nephrology, Columbia University Irving Medical Center, New York, New York, USA; Department of Epidemiology, The Columbia University Renal Epidemiology (CURE) Group, Columbia University, New York, New York, USA.
Jazyk: angličtina
Zdroj: Kidney international [Kidney Int] 2021 Jul; Vol. 100 (1), pp. 240-241. Date of Electronic Publication: 2021 Apr 30.
DOI: 10.1016/j.kint.2021.04.018
Databáze: MEDLINE